Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Cue Health Inc
(NQ:
HLTH
)
0.0434
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cue Health Inc
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 02, 2024
Via
Benzinga
Dow Down 100 Points; US Manufacturing PMI Falls In December
January 02, 2024
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.28% to 37,584.41 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
January 02, 2024
Shares of LumiraDx Limited (NASDAQ: LMDX) fell sharply in pre-market trading after the company agreed to sell its point-of-care technology platform to Roche. LumiraDx shares dipped 19.7% to $0.0517 in...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 02, 2024
Via
Benzinga
Cue Health: Q3 Earnings Insights
November 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 11, 2023
Via
Benzinga
Cue Health Reports Third Quarter 2023 Financial Results
November 08, 2023
From
Cue Health Inc.
Via
Business Wire
Cue Health to Announce Third Quarter 2023 Financial Results
October 25, 2023
From
Cue Health Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 25, 2023
Via
Benzinga
Independent Clinical Study Confirms Cue Health’s COVID-19 Test Is As Accurate As a Lab Test
October 20, 2023
--News Direct--
Via
News Direct
Exposures
COVID-19
Product Safety
Independent Clinical Study Confirms Cue Health's COVID-19 Test Is As Accurate As A Lab Test
October 19, 2023
A new study published in Microbiology Spectrum put Cue Health’s (NASDAQ: HLTH) COVID
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 18, 2023
Via
Benzinga
Concerned Stockholders of Cue Health Send Letter to Board
October 06, 2023
From
On behalf of Concerned Stockholders of Cue Health
Via
Business Wire
Peer-Reviewed Independent Study Published in Microbiology Spectrum Finds Cue Health’s Molecular COVID-19 Test is as Accurate as a Lab-Based PCR Test
October 04, 2023
From
Cue Health
Via
Business Wire
Cue Health Adopts Limited-Duration Shareholder Rights Plan
September 21, 2023
From
Cue Health Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
August 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 24, 2023
Via
Benzinga
Why Lands' End Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
August 31, 2023
Gainers Acer Therapeutics Inc. (NASDAQ: ACER) shares jumped 145% to $1.4850 after Zevra Therapeutics announced it will acquire the company. The transaction will have a total potential value for Acer...
Via
Benzinga
Cue Health to Present at Upcoming Investor Conferences
August 23, 2023
From
Cue Health Inc.
Via
Business Wire
This Healthcare Tech Company Has Become The First To Receive FDA De Novo Authorization For An OTC COVID-19 Test
August 18, 2023
--News Direct--
Via
News Direct
Exposures
COVID-19
Product Safety
This Healthcare Tech Company Has Become The First To Receive FDA De Novo Authorization For An OTC COVID-19 Test
August 17, 2023
The healthcare technology company Cue Health Inc. (NASDAQ: HLTH) has become the first company to get De Novo authorization from the U.S.
Via
Benzinga
Exposures
COVID-19
Product Safety
Cue Health Reports Second Quarter 2023 Financial Results
August 09, 2023
From
Cue Health Inc.
Via
Business Wire
Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use
August 03, 2023
From
Cue Health Inc.
Via
Business Wire
Cue Health to Announce Second Quarter 2023 Financial Results
July 26, 2023
From
Cue Health Inc.
Via
Business Wire
Cue Health’s Growing Integrated Care Platform Of Lab-Quality Diagnostic Tests For Use At-Home And At The Point-of-Care Is Transforming How Healthcare Is Delivered
July 25, 2023
--News Direct--
Via
News Direct
Exposures
COVID-19
Product Safety
Cue Health's Growing Integrated Care Platform Of Lab-Quality Diagnostic Tests For Use At-Home And At The Point-of-Care Is Transforming How Healthcare Is Delivered
July 24, 2023
Last month, the Food and Drug Administration (FDA) granted a landmark De Novo authorization for Cue Health’s (NASDAQ: HLTH) at-home COVID-19 test that
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.